Plus Therapeutics
PSTV
PSTV was delisted on the 31st of July, 2026.
3 hedge funds and large institutions have $32.1M invested in Plus Therapeutics in 2013 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
85% less call options, than puts
Call options by funds: $101K | Put options by funds: $687K
Top Buyers
Top Sellers
PSTV Hedge Fund Activity: Q2 2013 in Review
3 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q2 2013, worth a combined $32.1M.
Buyers outnumbered sellers: 3 funds opened new PSTV positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
- 3 institutional investors held Plus Therapeutics (PSTV) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $32.1M of Plus Therapeutics stock for Q2 2013.
- 3 funds opened new Plus Therapeutics positions in Q2 2013 and 0 closed out, a net change of +3 holders.
Based on aggregated 13F filings for Q2 2013.